Superficial Radiation Therapy Segment to Dominate the Global Market for Non-Melanoma Skin Cancer Treatment throughout the Projected Period

Albany, USA, 2017-Oct-13 — /EPR Network/ —The most common form of skin cancer is non-melanoma skin cancer which put a remarkable financial burden on various countries across the globe. The governments of numerous countries as well as the regulatory bodies have now become aware about this economic burden and therefore it is matter of great concerns for the authorities. “Non-Melanoma Skin Cancer Treatment Market: Global Industry Analysis (2012 – 2016) and Forecast (2017 – 2025),” is the new research report that has been added in the database of Market Research Reports Search Engine (MRRSE). This report for the non-melanoma skin cancer treatment market has the projection period of 8-years, i.e. between 2017 and 2025.

Request Free Sample Report: https://www.mrrse.com/sample/3471

Various Initiatives taken by the Government to Raise an Awareness

According to this research report, if not treated in the primitive stage, non-melanoma skin cancer can spread in an entire body, however it is curable if treated properly in an initial stage. Highest occurrence of this type of cancer is in APAC region and Australia’s population is the greatest suffer.  For instance, around 1800 people died of this type of cancer in Australia in 2016. At the end of the projected period, the market for non-melanoma skin cancer treatment in A & Z is likely to be valued more than US$ 705 Mn which is much larger than other parts of the Asia Pacific region

With Around 90% of Revenue Share, Radiation Therapy Grabs the Market

According to this research report, the radiation therapy segment is likely to go ahead with nearly US$ 4.8 Bn than photodynamic therapy and chemotherapy at the end of 2025. This segment is anticipated to capture around 90% market share in 2017. The healthy CAGR of 9.6% is witnessed in the segment of superficial radiation therapy during the assessed period which is comparatively latest treatment which has fewer side effects. An attractiveness index of radiation therapy segment is also higher than other segments in this market due to innovation and development in the portable devices of the radiation therapy.

Browse Full Report with TOC: https://www.mrrse.com/non-melanoma-skin-cancer-market

Lesser Side Effects with Superficial Radiation Therapy

An innovation and development in the machines which are associated with radiation therapy received widespread acceptance in the clinics of dermatology which are solely treatment the skin cancer of non-melanoma. According to this research report, these devices are in great demand and in use as they are having few side effects than other devices. For instance the device of SRT radiation therapy which is created by Sensus healthcare to treat this type of cancer is highly effective. Moreover this therapy has meagre side effects and more economical as compared to other traditional devices of therapy. In United States alone, as many as 300 devices of superficial radiation therapy were sold by Sensus Healthcare.

Global Non-Melanoma Skin Cancer Treatment Market

Elekta AB, Novartis AG, Almirall S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Mylan NV, Varian Medical Systems, Inc., Boehringer Ingelheim GmbH, Sensus Healthcare, iCAD, Inc., Sun Pharmaceutical Industries Ltd, Ion Beam Applications SA, F. Hoffmann-La Roche Ltd., and Accuray, Inc. are some of the key companies that are operating in the global non-melanoma skin cancer treatment market.

Enquire About this Report: https://www.mrrse.com/enquiry/3471

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

Matched content

Editor’s Pick